Skip to main content
Clinical Trials/NCT01078428
NCT01078428CompletedPhase 4

Effect of Transparent, Self-drying Silicone Gel on the Treatment of Hypertrophic Abdominal Scars

Mahidol University1 site in 1 country38 target enrollmentStarted: January 1, 2010Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
38
Locations
1
Primary Endpoint
Scar thickness

Study Overview

Brief Summary

Keloids and hypertrophic scars are a common subject of dermatologic consultations. Therapeutic management of such conditions remains challenging because of their high rate of recurrence and lack of curative treatment.

Detailed Description

Silicone gel Sheeting (SGS) is one treatment modality that has proven effective for treatment of hypertrophic scar. One disadvantage of SGS is its application technique. To be effective, SGS must be applied on the scar for at least 12 hours daily. Topical silicone gel is a novel therapy that has shown promising result on scar prevention. However, the efficacy and safety of topical silicone gel for treatment of hypertrophic scar has not been confirmed.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •subjects at least 18 years old
  • •subjects with hypertrophic abdominal scar
  • •Have not received treatment on the scar at least 1 month prior to the enrollment.

Exclusion Criteria

  • •subject who has previous history of silicone allergy
  • •subject who smoke cigarette
  • •subject who was treated with x-rays irradiation in the past

Arms & Interventions

Silicone gel

Active Comparator

Gel containing silicone gel

Intervention: Topical silicone gel (Other)

Vaseline

Placebo Comparator

Gel containing petrolatum gel

Intervention: Vaseline (Other)

Outcomes

Primary Outcomes

Scar thickness

Time Frame: 1, 2 and 5 months after initiation of treatment

Secondary Outcomes

  • Clinical assessment on overall scar appearance(1, 2 and 5 months after initiation of treatment)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Woraphong Manuskiatti, M.D.

Professor

Mahidol University

Study Sites (1)

Loading locations...

Similar Trials